COMMUNIQUÉS West-GlobeNewswire

Thetis Pharmaceuticals Awarded $2.3 Million Fast-Track NIH Grant to Develop Immuno-Resolving Therapy for Inflammatory Bowel Disease

16/11/2017 - 18:35

BRANFORD, Conn., Nov. 16, 2017 (GLOBE NEWSWIRE) -- Thetis Pharmaceuticals, a biopharmaceutical company developing “immuno-resolving” therapies for treatment of inflammatory bowel disease (IBD), today announced the [...]

Accelerate Diagnostics Welcomes Dr. Charles Watts to its Board of Directors

16/11/2017 - 18:06

TUCSON, Ariz., Nov. 16, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. today announced the election of Charles Watts, M.D. to the company’s board of directors. His appointment is effective November 14, 2017. Dr. [...]

Konica Minolta’s AeroRemote Insights Provides Interactive Analytic Reporting for Radiology Departments

16/11/2017 - 17:15

WAYNE, N.J., Nov. 16, 2017 (GLOBE NEWSWIRE) -- Konica Minolta Healthcare Americas, Inc., a recognized leader in medical imaging systems and healthcare IT, unveils AeroRemote™ Insights, a new web-based tool designed to [...]

GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 octobre 2017

16/11/2017 - 17:12

Communiqué de presse Villepinte, le 16 novembre 2017 DECLARATION RELATIVE AU NOMBRE DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL DE LA SOCIETE En application de l'article L. 233-8 II du code de commerce et de l' [...]

Nymox Fexapotide Symposium and Panel Discussion at American Urological Association North Central Sectional Annual Meeting in Scottsdale

16/11/2017 - 17:10

HASBROUCK HEIGHTS, N.J., Nov. 16, 2017 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX ) is pleased to report on the Symposium which was held on Fexapotide Triflutate studies at the Annual Meeting of [...]

The Chartis Center for Rural Health Celebrates National Rural Health Day with 2017 Performance Leadership Awards

16/11/2017 - 16:45

Portland, ME, Nov. 16, 2017 (GLOBE NEWSWIRE) -- In celebration of National Rural Health Day, The Chartis Center for Rural Health and iVantage Health Analytics today announced the recipients of the 2017 National [...]

Insider tradings

16/11/2017 - 16:20

Please see enclosed pdf.

New data shows more needs to be done to keep kids with diabetes safe at school

16/11/2017 - 16:00

OTTAWA, Nov. 16, 2017 (GLOBE NEWSWIRE) -- Nearly one-third of Ontario parents aren’t confident that school staff can keep their kids with type 1 diabetes safe, according to new data released today by the Canadian [...]

Premier Biomedical Appoints Carl Eller, NFL Retired Players Association President, as Marketing & Planning Vice-President

16/11/2017 - 16:00

El Paso, Texas, Nov. 16, 2017 (GLOBE NEWSWIRE) -- Premier Biomedical, Inc. (OTCQB: " BIEI ") announced the appointment of retired NFL Pro Football Hall of Famer, Carl Eller, to the post of Marketing and Planning Vice- [...]

Rafael Pharmaceuticals, in Collaboration with Atlantic Health System, Announces Initiation of a Phase I Study of CPI-613 in Combination with Gemcitabine and Nab-Paclitaxel for Patients with Locally Advanced or Metastatic Pancreatic Cancer

16/11/2017 - 15:25

Newark, NJ, Nov. 16, 2017 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc., a clinical stage company and leader in the field of cancer metabolism-based therapeutics, announced today, the initiation of a Phase I clinical [...]

Zomedica Pharmaceuticals Corp. Expects Trading of its Common Shares on the NYSE American to Commence on November 21, 2017

16/11/2017 - 15:12

ANN ARBOR, Mich., Nov. 16, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V: ZOM ) (NYSE American:ZOM) (“Zomedica” or “Company”), a veterinary pharmaceutical and health care solutions company, today [...]

MRI Interventions’ ClearPoint® NeuroNavigation System Achieves 2000th Procedure Milestone

16/11/2017 - 15:00

IRVINE, Calif., Nov. 16, 2017 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) today announced the 2000 th procedure completed with the ClearPoint NeuroNavigation System. The procedure was done by Dr. William [...]

IDVV announces OTC Markets Tier Upgrade as Part of Planned Company Restructure

16/11/2017 - 15:00

TEMECULA, Calif., Nov. 16, 2017 (GLOBE NEWSWIRE) -- International Endeavors Corporation (OTC:IDVV) ("IEC") today announced it has received Pink Current Status from OTC Markets as part of the company’s corporate [...]

OrthoPediatrics Corp. to Participate in the 29th Annual Piper Jaffray Healthcare Conference

16/11/2017 - 15:00

WARSAW, Ind., Nov. 16, 2017 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS ), a company exclusively focused on advancing the field of pediatric orthopedics, announced today that Mark [...]

AxoGen, Inc. Announces Pricing of Public Offering of Common Stock

16/11/2017 - 14:40

ALACHUA, Fla., Nov. 16, 2017 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ: AXGN ), a global leader in developing and marketing innovative surgical solutions for the repair of peripheral nerve damage, announced today that it [...]

Onconova Therapeutics Announces Data on Improved Formulation of Rigosertib and Next-Generation CDK4/6 Inhibitor at 2017 American Association of Pharmaceutical Scientists Annual Meeting

16/11/2017 - 14:30

Novel formulation of rigosertib with enhanced bioavailability and stability Liver microsomal stability of ON 123300, a first-in-class dual inhibitor of CDK4/6 + ARK5 Formulation approaches to augment bioavailability of [...]

Pernix Therapeutics Announces Election of Two Healthcare Industry Veterans to Board of Directors

16/11/2017 - 14:30

MORRISTOWN, N.J., Nov. 16, 2017 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ: PTX ) (“Pernix” or the “Company”), a specialty pharmaceutical company, today announced the election of two new directors to [...]

Ultragenyx Announces Completion of Patient Dosing in First Cohort of Phase 1/2 Clinical Study of DTX301 Gene Therapy in Ornithine Transcarbamylase (OTC) Deficiency

16/11/2017 - 14:30

NOVATO, Calif., Nov. 16, 2017 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE ), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today [...]

ARCA Biopharma Announces Issuance of European Patent for Treating Cardiovascular Diseases and Conditions With a New Chemical Entity Utilizing Genetic Targeting

16/11/2017 - 14:30

WESTMINSTER, Colo., Nov. 16, 2017 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO ), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies for [...]